Skip to main content
Premium Trial:

Request an Annual Quote

Ambry Genetics to Offer SoftGenetics' Software

NEW YORK (GenomeWeb News) – Ambry Genetics said today that under a new exclusive agreement it will provide bioinformatics services from SoftGenetics to its next-generation sequencing customers.

The genomics and clinical services firm said it will offer SoftGenetics' NextGENe software for projects it performs in its labs. The NextGENe analysis software works in a freestanding Windows-based program and is compatible with all major next-generation sequencing systems, Ambry said.

"While some of our clients are interested in performing their own analyses, others are asking for extended support," Ambry Chief Scientific Officer Anja Kammesheidt said in a statement. "In light of diversifying applications, increasing project sizes, and new genomes to be explored, having a proven and innovative partner for bioinformatics is key."

John Fosnacht, SoftGenetics VP of sales and marketing, said the agreement combines Ambry's sequencing with the "unique analysis capabilities of NextGENe without the heavy investment typically required in next-generation sequencing instrumentation and heavy bioinformatics."

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.